CEFTIN CEFUROXIME 250MG 14TABS

$55.99

Ceftin contains 250 mg of cefuroxime, a second-generation cephalosporin antibiotic. It is used to treat bacterial infections such as respiratory tract infections, skin infections, sinusitis, and urinary tract infections. Cefuroxime works by inhibiting bacterial cell wall synthesis, effectively eliminating the infection

Description

ZINNAT® is an oral prodrug of cefuroxime, the bactericidal cephalosporin antibiotic, resistant to most beta-lactamases and active against a wide variety of gram-positive and gram-negative microorganisms. It is indicated for the treatment of infections caused by sensitive bacteria.

Susceptibility to ZINNAT® will vary with geography and time, and local susceptibility information should be consulted, where available (see Pharmacokinetics and Pharmacodynamics).

Indications include:

• Infections of the upper respiratory tract, for example, ear, nose and throat infections, such as otitis media, sinusitis, tonsillitis and pharyngitis.

• Lower respiratory tract infections, eg pneumonia, acute bronchitis, and acute exacerbations of chronic bronchitis.

• Genitourinary tract infections, for example pyelonephritis, cystitis and urethritis.

• Infections of the skin and soft tissues, for example :, furunculosis, pyoderma and impetigo.

• Gonorrhea, uncomplicated acute gonococcal urethritis, and cervicitis.

• Treatment of early-stage Lyme disease and subsequent prevention of late-stage Lyme disease.

Cefuroxime is also available as the sodium salt (ZINNAT® Solution for injection), for parenteral administration. This allows the use of sequential therapy with the same antibiotic in situations where a change from parenteral to oral therapy is clinically indicated.

In suitable situations, ZINNAT® is effective when used after initial therapy with ZINNAT® (cefuroxime sodium) solution for injection, in the treatment of pneumonia and acute exacerbations of chronic bronchitis.

Indications:
Ceftin is prescribed for the treatment of:

  • Respiratory Tract Infections: Such as bronchitis, sinusitis, and pneumonia.
  • Skin and Soft Tissue Infections: Including cellulitis, impetigo, and abscesses.
  • Urinary Tract Infections: Including cystitis and pyelonephritis.
  • Ear Infections (Otitis Media): Common in both adults and children.

Key Features:

  • Broad-Spectrum Antibiotic: Effective against gram-positive and gram-negative bacteria.
  • Well-Tolerated: Proven safety profile with minimal side effects.
  • Convenient Dosing: Typically taken twice daily for better adherence.

Dosage and Administration:

  • Take as directed by a healthcare provider, usually every 12 hours.
  • Swallow tablets whole with water; do not crush or chew.
  • Can be taken with or without food; taking with food may improve absorption and reduce stomach upset.

Contraindications and Precautions:

Contraindications:

  • Hypersensitivity to cefuroxime or other cephalosporin antibiotics.

Precautions:

  • Inform your healthcare provider of any history of kidney or liver disease.
  • Use with caution in patients with a history of gastrointestinal disorders, particularly colitis.
  • Complete the prescribed course to prevent antibiotic resistance.

Side Effects:

  • Common: Nausea, diarrhea, abdominal discomfort, and mild rash.
  • Serious: Allergic reactions, severe diarrhea, or liver function changes. Seek medical attention for severe or unusual symptoms.

Storage Instructions:

  • Store at room temperature (15–30°C), away from moisture and heat.
  • Keep out of reach of children.

Packaging:

  • Contains 14 tablets, each with 250 mg of cefuroxime.

Why Choose Ceftin 250 mg Tablets?
Ceftin provides reliable and effective treatment for a variety of bacterial infections. Its broad-spectrum action, proven efficacy, and convenient dosing make it a trusted choice for infection management under the guidance of a healthcare provider.

CEFTIN CEFUROXIME 250MG 14TABS

Reviews

There are no reviews yet.

Be the first to review “CEFTIN CEFUROXIME 250MG 14TABS”

Your email address will not be published. Required fields are marked *

Scroll to top